ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

ASCO And ESMO Publish Training Recommendations

November 26, 2004

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back

March 2, 1984

Prevention Trial Could Stand On Its Own

October 28, 1994

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003